20 reports

  • PROJECTED PREVALENCE OF CVDS IN US
  • Advance its product pipeline through increased investment in R&D activities
  • Heart Attack
  • AstraZeneca PLC
  • Novartis AG
  • NSTEMI group
  • Pfizer Inc.
  • 5.1 CARDIOVASCULAR TESTING
  • 19.4 SIEMENS HEALTHINEERS OFFERS TRUE HIGH-SENSITIVITY TROPONIN I IVD

High-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks.

  • Heart Attack
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Boditech Med Inc.
  • Heart Attack - Recent Pipeline Updates
  • Heart Attack - Pipeline by Lacer, S.A., H2 2015
  • Chronic Disease
  • Heart Attack
  • Pathology
  • World
  • Heart Attack - Recent Pipeline Updates
  • Heart Attack - Dormant Projects, H1 2015
  • Chronic Disease
  • Heart Attack
  • Pathology
  • World
  • Aug 27, 2017: Anti-inflammatory drug could reduce risk of second heart attack
  • Jun 22, 2017: Novartis Phase III study shows ACZ885 reduces cardiovascular risk in people who survived a heart attack
  • Heart Attack
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • SMALL MOLECULE FOR REPERFUSION INJURY AND HEART ATTACK - DRUG PROFILE
  • Jun 14, 2016: Thymosin Beta 4 Effective in Treatment of Heart Attack Patients
  • Heart Attack
  • Hospital
  • Pharmaceutical
  • Therapy
  • Athersys, Inc.
  • SMALL MOLECULE FOR REPERFUSION INJURY AND HEART ATTACK - DRUG PROFILE
  • Jun 14, 2016: Thymosin Beta 4 Effective in Treatment of Heart Attack Patients
  • Chronic Disease
  • Heart Attack
  • United States
  • Product Initiative
  • Athersys, Inc.
  • DIAGNOSTIC BLOOD TEST - HEART ATTACK - PRODUCT STATUS
  • DIAGNOSTIC BLOOD TEST - HEART ATTACK - PRODUCT DESCRIPTION
  • Clinical Trial
  • Heart Attack
  • Immunochemistry Test
  • United States
  • GlobalData's company
  • JUN 01, 2015: NEUROVIVE REPORTS TOPLINE RESULTS OF PHASE III CIRCUS STUDY IN ACUTE MYOCARDIAL INFARCTION
  • MAY 25, 2015: NEUROVIVE PHARMACEUTICAL: TOPLINE RESULT OF PHASE III STUDY OF CICLOMULSION IN ACUTE MYOCARDIAL INFARCTION EXPECTED THIS QUARTER
  • Heart Attack
  • Hospital
  • World
  • Product Initiative
  • CicloMulsion AG
  • Angion Biomedica Corp. - Recent Pipeline Updates, 2015
  • Product Description

The study will evaluate the effect of BB## to preserve myocardial (heart) tissue and function following myocardial infarction (heart attack).

  • Heart Attack
  • Therapy
  • United States
  • Product Initiative
  • Angion Biomedica Corp.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Heart Disease), Coronary Disease, Renal Failure, Stroke Ongoing, recruiting Phase III Interventional exenatide Rigshospitalet ## Feb 2016 ## Jan 2020 ## ## ## Glucagon Like Peptide ## Receptor (GLP##R) Agonist Glucagon Like Peptide ## Receptor (GLP##R) Hemodynamic Effects of Vasopressin Adminis

  • Health Services
  • Heart Attack
  • World
  • Product Initiative
  • BTG plc
  • MAY 20, 2014: STENTYS SIROLIMUS-ELUTING STENT DEMONSTRATES BEST IN CLASS EFFICACY FOR HEART ATTACK PATIENTS
  • CID S.R.L. COMPANY OVERVIEW
  • Clinical Trial
  • Drug Discovery And Development
  • Heart Attack
  • Interventional Cardiology Device
  • GlobalData's company
  • Clinical Trial profile. 678 Trial Title
  • Clinical Trial profile. 438 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Heart Attack
  • Therapy
  • World
  • Clinical Trial profile. 38 Trial Title
  • Cardiology
  • Drug Discovery And Development
  • Heart Attack
  • World
  • Product Initiative

They are coming in with a heart attack.

  • Heart Attack
  • Interventional Cardiology Device
  • United States
  • Product Initiative
  • Abbott Vascular, Inc.
  • Clinical Trial Profile Snapshots

Heart Efficiency and Regeneration Trial) GDCT## NCT##, BMI-US-##-## Cardiovascular Congestive Heart Failure (Heart Failure), Coronary Artery Disease (CAD) (Ischemic Heart Disease), Post-Myocardial Infarction Completed Phase I Interventional MyoCell U. S.

  • Cardiovascular Disease
  • Heart Attack
  • Therapy
  • World
  • Novartis AG

Heart with Doxycycline During Coronary Artery Bypass Grafting: A Pilot Study Protection of the Heart with Doxycycline During Coronary Artery Bypass Grafting GDCT## NCT##, Cardiovascular Reperfusion Injury (## kDa Type IV Collagenase (Matrix Metalloproteinase ## or Gelatin

  • Cardiology
  • Drug Discovery And Development
  • Heart Attack
  • World
  • Product Initiative
  • Phase I - Trial Details

Research into CicloMulsion s efficacy beyond the treatment of reperfusion injury following heart attack grew out of the concept of mitochondrial protection in connection with organ injury focusing on heart disease.

  • Heart Attack
  • Pharmaceutical
  • World
  • Product Initiative
  • CicloMulsion AG
  • Clinical Trial Profile Snapshots

Heart Attack GDCT## NCT##, ARG-CS##-## Other Diseases Cardiogenic Shock Terminated Phase III Interventional tilarginine acetate ArgiNOx Pharmaceuticals, Inc. ## May 2005 ## Aug 2006 ## ## ## Efficacy of Levosimendan in the Critically Ill Patients with Unstable Hemodynamic

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • BTG plc

At the heart of Vereos is a state-of-the-art detector that converts detected photons directly into digital information.

  • CT Scan
  • Fetal Monitoring
  • Healthcare
  • Heart Attack
  • GlobalData's company